N-SUBSTITUTED IMINES OF HEXAFLUOROACETONE
603
Scheme 2.
O
CH3O(O)C
CF3
N
N
N
NH2
+
N
C
R
O
C
_CH3OH
NH
N
H
NH
CF3
VIa_VId
R
O
Va_Vd
I
V, VI: R = i-C3H7 (а), 3-CH3-C6H4 (b), 2-F-C6H4 (c), 4-F-C6H4 (d).
contained characteristic signals. The signal of CF3-
group in the 19F NMR spectrum of IV appears at
–2.16 ppm; in the case of compounds VIa–VId this
signal lies in the range of 1.83–2.66 ppm (Scheme 2).
266°C. 1Н NMR spectrum (DMSO-d6), δ, ppm: 0.77 d
(3H, Me, J 7.1 Hz), 0.90 d (3H, Me, J 7.1 Hz), 2.59 m
(1H, CH), 7.06–7.19 m (3H, CHAr), 7.43 t (1H, CHAr,
J 5.9), 10.11 s (1H, NH), 12.74 br.s (1H, NH). 19F
NMR spectrum (DMSO-d6): δF 1.83 ppm. Found, %: C
51.73; H 3.84; N 17.31. C17H13F3N4O2. Calculated, %:
C 51.55; H 4.02; N 17.17.
Hence the cyclocondensation of 2-amino-benzo-
imidazole with N-substituted imines of hexafluoro-
acetone and methyl trifluoropyruvate resulted in
trifluoromethyl-containing benzo[4,5]imidazo[1,2-a]-
[1,3,5]triazin-4-one and 2,3-dihydro-1H-imidazo-
[1,2-a]benzimidazol-2-ylamides.
3-Methyl-N-(2-trifluoromethyl-3-oxo-2,3-dihydro-
1H-imidazo[1,2-a]benzimidazol-2-yl)benzamide (VIb)
was obtained similarly. Yield 72%, mp 251–253°C. 1Н
NMR spectrum (DMSO-d6), δ, ppm: 2.07 s (3H, Me),
7.12–7.27 m (1H, CHAr), 7.30–7.38 m (1H, CHAr),
7.43–7.53 m (6H, CHAr), 10.75 s (1H, NH), 13.04 br.s
(1H, NH). 19F NMR spectrum (DMSO-d6): δF 2.20 ppm.
Found, %: C 57.62; H 3.32; N 15.18. C18H13F3N4O2.
Calculated, %: C 57.76; H 3.50; N 14.97.
Ethyl [1-(1H-benzimidazol-2-yl)amino-2,2,2-tri-
fluoro-1-trifluoromethylethyl]carbamate (III). To a
suspension of 5 mmol of compound I in 10 mL of
benzene was added 5 mmol of II while stirring at 20°C.
The reaction mixture was stirred for 1 h at 50°C, then
cooled, and evaporated. The residue was recrystallized
from hexane. Yield 1.6 g, 86%, mp > 300°C. 1Н NMR
spectrum (DMSO-d6), δ, ppm: 1.06 t (3H, Me, J 7.1 Hz),
3.94 q (2Н, СН2О, J 7.2 Hz), 6.78–6.91 m (2H, CHAr),
6.97–7.12 m (2H, CHAr), 6.38 (1H, NH), 8.36 (1H,
NH), 10.44 (1H, NH). 19F NMR spectrum (DMSO-d6):
δF 3.68 ppm. Found, %: C 42.38; H 3.49; N 15.31.
C13H12F6N4O2. Calculated, %: C 42.17; H 3.27; N
15.13.
N-(2-Trifluoromethyl-3-oxo-2,3-dihydro-1H-imi-
dazo[1,2-a]benzimidazol-2-yl)-2-fluorobenzamide (VIc)
was prepared similarly. Yield 69%, mp 230–232°C. 1Н
NMR spectrum (DMSO-d6), δ, ppm: 6.86–7.15 m (5H,
CHAr), 7.19–7.42 m (3H, CHAr), 10.59 s (1H, NH),
19
12.85 br.s (1H, NH). F NMR spectrum (DMSO-d6),
δF, ppm: 2.12 (3F, CF3), from –35.53 to –35.60 m (1F,
CFAr). Found, %: C 53.72; H 2.42; N 14.60.
C17H10F4N4O2. Calculated, %: C 53.98; H 2.66; N 14.81.
2,2-Bis(trifluoromethyl)-2,3-dihydro-1H-benzo-
[4,5]imidazo[1,2-a][1,3,5]triazin-4-one (IV). A solu-
tion of 5 mmol of compound III in 10 mL of DMF
was heated for 2 h at 90°C, then cooled, and poured
into 50 mL of water. The precipitate was recrystallized
from 50% EtOH. Yield 1.2 g, 74%, mp 304–306°C. 1Н
NMR spectrum (DMSO-d6), δ, ppm: 6.90–7.18 m (3H,
CHAr), 7.70 d (1Н, CHAr, J 7.7 Hz), 9.92 s (1H, NH),
11.81 (1H, NH). 19F NMR spectrum (DMSO-d6): δF
–2.16 ppm. Found, %: C 40.58; H 1.66; N 17.51.
С11H6F6N4O. Calculated, %: C 40.76; H 1.87; N 17.28.
N-(2-Trifluoromethyl-3-oxo-2,3-dihydro-1H-imi-
dazo[1,2-a]benzimidazol-2-yl)-4-fluorobenzamide
(VId) was prepared similarly. Yield 72 %, mp 269–
1
271°C. Н NMR spectrum (DMSO-d6), δ, ppm: 7.08–
7.20 m (2H, CHAr), 7.22–7.37 m (3H, CHAr), 7.41–
7.49 m (1H, CHAr), 7.82–7.98 m (1H, CHAr), 10.54 s
(1H, NH), 12.74 br.s (1H, NH). 19F NMR spectrum
(DMSO-d6), δF, ppm: 2.66 s (3F, CF3), from –28.76 to
–29.06 m (1F, CFAr). Found, %: C 53.70; H 2.41; N
14.64. C17H10F4N4O2. Calculated, %: C 53.98; H 2.66;
N 14.81.
N-(2-Trifluoromethyl-3-oxo-2,3-dihydro-1H-imi-
dazo[1,2-a]benzimidazol-2-yl)isobutyramide (VIa)
was prepared similarly. Yield 1.2 g, 76%, mp 264–
1H and 19F NMR spectra were recorded on a Bruker
DPX 200 spectrometer at 200.13 and 188.29 MHz,
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 84 No. 3 2014